[Amiloride reduces proteinuria and inhibits podocyte uPAR in the 5/6 nephrectomy rats]

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Nov;34(11):1654-7.
[Article in Chinese]

Abstract

Objective: To observe the effect of amiloride on the proteinuria of the 5/6 nephrectomy rats.

Methods: To establish the 5/6 nephrectomy rats model and divide the experiment into 3 groups, sham operated group(Sham), 5/6 nephrectomy model group(NTX) and 5/6 nephrectomy with amiloride-treated group (NTX+amiloride, n=15). The concentration of protein and mRNA of uPAR and the change of podocytes motility were detected by coomassiebluestaining, immunofluorence method and real-time PCR.

Results: At second week, compared with Control group, the 24 h urine protein of NTX group was significantly increased (47.50 ± 28.05 mg vs 14.28 ± 3.8 mg, P = 0.023). There was no statistical significance in 24-hour urine protein between NTX+amiloride group and NTX group (51.56 ± 21.03 mg vs 47.50 ± 28.05 mg, P = 0.748). The same situation was also observed at the time point of 12 week, comparing with NTX group, 24-hour urine protein decreased in Sham group (188.31 ± 29.82 mg vs 21.32 ± 8.59 mg, P = 0.000) and NTX+amiloride group (188.31 ± 29.82 mg vs 121.37 ± 31.14 mg, P=0.000), with statistical significance when comparing with Sham group, the expression of uPAR mRNA in NTX group was significantly increased (9.74 ± 1.44 vs 1.01 ± 0.13, P = 0.000). In contrast, the expression of uPAR mRNA in NTX rats treated with amiloride was significantly lower than in NTX group (9.74 ± 1.44 vs 5.01 ± 1.36, P = 0.000).

Conclusion: Amiloride can reduce the proteinuria of the 5/6 nephrectomy rats model of transient proteinuria by inhibiting the induction of uPAR expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiloride / pharmacology*
  • Animals
  • Cell Movement
  • Disease Models, Animal
  • Nephrectomy
  • Podocytes / drug effects*
  • Podocytes / metabolism
  • Proteinuria / drug therapy*
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Receptors, Urokinase Plasminogen Activator / metabolism*

Substances

  • Receptors, Urokinase Plasminogen Activator
  • Amiloride